Spatiotemporal Sequential Delivery of Chidamide Regulates Macrophage Reprogramming in Lymphoma Microenvironment Through HDACs‐STAT3 Pathway
Advanced Science · 2026-07 · 13 (38)
DOI: 10.1002/advs.202502791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 31.03.2026. Verfasst von Bo Dai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Benzamides, STAT3 Transcription Factor, Tumor Microenvironment, Aminopyridines. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural & Science Foundation of China, Science and Technology Innovation Plan of Shanghai Science and Technology Commission.
Abstract (Originalsprache)
Tumor‐associated macrophage (TAM) is an important component of immunosuppressive microenvironment, which has been indicated as a key contributor in the relapse of diffuse large B‐cell lymphoma (DLBCL). However, the molecular mechanism and the potential intervention regulating DLBCL‐TAMs remains undefined. Here, we found that histone deacetylases (HDACs)‐induced STAT3 deacetylation was critical for the M2 macrophages accumulation in DLBCL. Considering the unignorable adverse effects of HDAC inhibitor chidamide in DLBCL treatment, we developed a M2‐targeted delivery system with peptide‐modified extracellular vesicle (M2pep‐EVs) to obtain optimized intra‐tumour delivery of chidamide. In combined with pH‐responsive hydrogel TSPBA/PVA, chidamide was loaded in M2pep‐EVs, and was intelligently released as Chid@M2pep‐EVs in situ in the acidic lymphoma microenvironment. By targeted delivery to M2 macrophages, chidamide sufficiently inhibited HDACs, enhanced STAT3 acetylation, reprogrammed M2 proportion into M1 phenotype, and ultimately suppressed lymphoma growth in vivo. With reduced dosage and adverse reactions, our Chid@M2pep‐EVs system provides a new translational strategy for treating refractory/relapsed lymphoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
- Center of Precision Medicine For Blood Diseases, Fudan University, Shanghai, China.
- Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Gynecology, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Ton…
- Obstetrics, and Gynecology Hospital, Fudan University, Shanghai, China.
- Department of Hematology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Förderung
- National Key R&D Program of China
- National Natural & Science Foundation of China
- Science and Technology Innovation Plan of Shanghai Science and Technology Commission
- Shanghai Eastern Talent Program (2022)
- National Key Research and Development Program of China
Zitieren
APA
Dai, B., Wang, S., Peng, X., Wu, K., Wu, M., Lu, Z., Zhong, H., Qian, X., Tan, S., Yang, H., Sun, T., Wang, J., Zhang, J., Jiang, H., Tong, Y., & Chen, T. (2026). Spatiotemporal Sequential Delivery of Chidamide Regulates Macrophage Reprogramming in Lymphoma Microenvironment Through HDACs‐STAT3 Pathway. Advanced Science, 13(38). https://doi.org/10.1002/advs.202502791
Vancouver
Dai B, Wang S, Peng X, Wu K, Wu M, Lu Z, et al. Spatiotemporal Sequential Delivery of Chidamide Regulates Macrophage Reprogramming in Lymphoma Microenvironment Through HDACs‐STAT3 Pathway. Advanced Science. 2026;13(38). doi:10.1002/advs.202502791
BibTeX
@article{Dai2026,
author = {Dai, Bo and Wang, Shuo and Peng, Xiaotong and Wu, Kunpeng and Wu, Mengyao and Lu, Zhaoning and Zhong, Haoshu and Qian, Xiaohan and Tan, Shuiyi and Yang, Hui and Sun, Tanlezi and Wang, Jing and Zhang, Jie and Jiang, Hua and Tong, Yin and Chen, Tong},
title = {Spatiotemporal Sequential Delivery of Chidamide Regulates Macrophage Reprogramming in Lymphoma Microenvironment Through HDACs‐STAT3 Pathway},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {38},
doi = {10.1002/advs.202502791}
}
EUVIMED